IGHE and atopic asthma: To counteract the pathologic effects of IgE in atopic asthma humanized anti-IgE antibodies such as Omalizumab have been introduced as a therapeutic concept, and they have been clinically proven to achieve additional beneficial effects on airway wall remodeling compared to standard therapy by inhaled glucocorticoids and long acting β2-agonists [3–5].